Kraków, Malopolskie

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Epilepsy2 trials

Phase

• Phase 22 trials

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• AbbVie2 trials

Closed trials

• Terminated

  An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04686786· Phase 2· AbbVie· Source

• Completed

  A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

  NCT04244175· Phase 2· AbbVie· Source